Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer

U. Berger, P. Wilson, R. A. McClelland, K. Colston, Mark R Haussler, J. W. Pike, R. C. Coombes

Research output: Contribution to journalArticle

60 Scopus citations


We have developed an immunocytochemical technique to visualize the receptor for 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] in cryostat sections of human breast tumors and normal human breast tissue utilizing a monoclonal antibody (9A7γ) to chick intestinal receptor which recognizes mammalian 1,25(OH)2D3 receptor. Specific staining was observed in the nuclei of tumor cells. Previous studies by our group have shown that a high proportion of breast tumors bind radiolabeled 1,25(OH)2D3 and we have confirmed this, demonstrating immunocytochemical 1,25(OH)2D3 receptor in 43 of 55 (78%) of breast carcinomas. No correlation with the presence of immunostainable estrogen receptor was found in these breast cancer specimens. Sections of normal breast showed immunoreactivity in the nuclei of epithelial cells of the lobules and ducts. Our results demonstrate that the receptor for 1,25(OH)2D3 resides predominantly in the nucleus of breast carcinoma cells. The reason for its predominant expression in breast cancers is not yet known but may be related to growth regulation.

Original languageEnglish (US)
Pages (from-to)6793-6799
Number of pages7
JournalCancer Research
Issue number24 I
Publication statusPublished - 1987


ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Berger, U., Wilson, P., McClelland, R. A., Colston, K., Haussler, M. R., Pike, J. W., & Coombes, R. C. (1987). Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer. Cancer Research, 47(24 I), 6793-6799.